De novo mutation in the BTK of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 5, 2006, Pages 744-748

  Lin, Mao Tsair ^a,b   Chien, Yin Hsiu ^c   Shyur, Shyh Dar ^a   Huang, Li Hsin ^a   Chiang, Yi Chi ^a   Wen, Da Chin ^a   Liang, Pei Hsuan ^a   Yang, Hwai Chih ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRUTON TYROSINE KINASE; CD3 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; B LYMPHOCYTE; BTK GENE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DNA SEQUENCE; FLOW CYTOMETRY; GENE; GENE MUTATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PYODERMA; RECURRENT INFECTION; WOUND; X LINKED AGAMMAGLOBULINEMIA;

EID: 33646742843     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61075-7     Document Type: Article

References (21)

1. Ochs HD, Winkelstein JA. Antibody deficiencies. In: Ochs HD, Winkelstein JA, Stiehm ER, eds. Immunologic Disorders in Infants & Children. 5th ed. Philadelphia, PA: Elsevier Saunders; 2004;357-369.
2. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaerma is a member of the src family of protein-tyrosine kinase. Nature. 1993;361:226-233.
3. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145-156.
4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
5. Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000;19:183-204.
6. Ochs HD, Smith CI. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine. 1996;75:287-299.
7. Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R. Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol. 2000;17:91-96.
8. Gerrard J, Alfredson D, Smith I. Recurrent bacteremia and multifocal lower limb cellulitis due to Helicobacter-Yike organisms in a patient with X-linked hypogammaglobulinemia. Clin Infect Dis. 2001;33:116-118.
9. Cuccherini B, Chua K, Gill V, et al. Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species. Clin Immunol. 2000;97:121-129.
10. Tokuda K, Nishi J, Miyanohara H, et al. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J. 2004;23:577-579.
11. Kerstens PJ, Endtz HP, Meis JF, et al. Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis. 1992;11:842-847.
12. Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985;134:3070-3074.
13. Hermaszewski RA, Webster ADB. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1996;86:31-42.
14. Kanegane H, Tsukada S, Iwata T, et al. Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry. Clin Exp Immunol. 2000;120:512-517.
15. Saffran DC, Parolini O, Fitch-Hilgenberg ME, et al. A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med. 1994;330:1488-1491.
16. Caspar HB, Ferrando M, Caragol I, et al. Kinase mutant BTK results in atypical X-linked agammaglobulinaemia phenotype. Clin Exp Immunol. 2000;120:346-350.
17. Jones A, Bradley L, Alterman L, et al. X linked agammaglobulinaemia with a "leaky" phenotype. Arch Dis Child. 1996;74:548-549.
18. Stewart DM, Tian L, Nelson DL. A case of X-linked agammaglobulinemia diagnosed in adulthood. Clin Immunol. 2001;99:94-99.
19. Kornfeld SJ, Kratz J, Haire RN, et al. X-linked agammaglobulinemia presenting as transient hypogammaglobulinemia of infancy. J Allergy Clin Immunol. 1995;95:915-917.
20. Liese JG, Wintergerst U, Tympner KD, Belohradsky BH. High vs. low dose immunoglobulin therapy in the long term treatment of X-linked agammaglobulinemia. Am J Dis Child. 1992;146:335-339.
21. Orlandi P, Ritis K, Moschese V, et al. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients. Hum Mutat. 2000;15:117.